We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Mammography AI Could Sharply Reduce Radiology Workload

By MedImaging International staff writers
Posted on 12 Jul 2021
Print article
Image: Transpara AI can reduce mammography workload (Photo courtesy of ScreenPoint Medical)
Image: Transpara AI can reduce mammography workload (Photo courtesy of ScreenPoint Medical)
Using artificial intelligence (AI) in breast cancer screening could reduce the workload of radiologists by up to 70% without reducing cancer detection rates, according to a new study.

The study, by researchers at Maimonides Institute for Biomedical Research (IMIBIC; Córdoba, Spain) and ScreenPoint Medical (Nijmegen, the Netherlands), compared a simulated AI triaging strategy using ScreenPoint’s Transpara AI software with double or single reading by radiologists in a retrospective analysis of 15,987 digital breast tomosynthesis (DBT) and digital mammography (DM) images from the Córdoba Tomosynthesis Screening Trial.

The examinations included 98 screening-detected and 15 interval cancers. The results showed that in comparison with double reading of DBT images, AI with DBT would result in 72.5% less workload, non-inferior sensitivity, and a and 16.7% lower recall rate. Similar results were obtained for AI with DM; compared to the original double reading of DM images, AI with DM would result in 29.7% less workload, 25% higher sensitivity, and 27.1% lower recall rate. The study was published on May 4, 2021, in Radiology.

“DBT images can take twice as long for radiologists to read compared with DM. However, with AI, it may be possible to move from using digital mammograms to digital breast tomosynthesis,” said lead author radiologist José Luis Raya-Povedano, MD, of the IMIBIC Breast Cancer Unit. “The workflow of breast cancer screening programs could be improved, given the high workload and the high number of false-positive and false-negative assessments.”

Transpara is based on FusionAI, a combination of pathology, clinical imaging, X-ray physics, and deep learning (DL) techniques, designed to improve mammography reading accuracy, help interpretation of suspicious areas, increase confidence for normal and suspicious cases, and speed up reading of 2D and 3D mammograms.

Related Links:
Maimonides Institute for Biomedical Research
ScreenPoint Medical


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
Dose Calibration Electrometer
PC Electrometer
MRI System
uMR 588

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.